K M Hwang - JoVE Visualize

Showing results (11-20 of 23) with videos related to

Pageof 3

Sort By:

Journal of the National Cancer Institute|May 1, 1986

Dynamic interaction of 111indium-labeled monoclonal antibodies with surface antigens of solid tumors visualized in vivo by external scintigraphyK M Hwang, A M Keenan, J Frincke, et al.

Biochemical Pharmacology|April 15, 1992

CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitroD M Rausch, J D Lifson, M P Padgett, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990

Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formationV S Kalyanaraman, D M Rausch, J Osborne, et al.

Science (New York, N.Y.)|August 5, 1988

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicityJ D Lifson, K M Hwang, P L Nara, et al.

Blood|May 1, 1988

High titer anti-HIV antibody reactivity associated with a paraprotein spike in a homosexual male with AIDS related complexV L Ng, K M Hwang, G R Reyes, et al.

Journal of Medicinal Chemistry|July 24, 1992

Antitumor agents. 134. New shiraiachrome-A- and calphostin-C-related perylene derivatives as cytotoxic and antiviral agents and inhibitors of protein kinase CH K Wang, J X Xie, J J Chang, et al.

Annals of the New York Academy of Sciences|January 1, 1990

Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV therapeutic agentsD M Rausch, K M Hwang, M Padgett, et al.

Cancer Research|November 1, 1976

Mode of action of the bioreductive alkylating agent, 2,3-bis(chloromethyl)-1,4-naphthoquinoneL A Cosby, R S Pardini, R E Biagini, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989

GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineageM S McGrath, K M Hwang, S E Caldwell, et al.

Science (New York, N.Y.)|October 28, 1983

Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumorJ N Weinstein, M A Steller, A M Keenan, et al.

Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:

Pageof 3

Journal of the National Cancer Institute|May 1, 1986

Dynamic interaction of 111indium-labeled monoclonal antibodies with surface antigens of solid tumors visualized in vivo by external scintigraphyK M Hwang, A M Keenan, J Frincke, et al.

Biochemical Pharmacology|April 15, 1992

CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitroD M Rausch, J D Lifson, M P Padgett, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990

Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formationV S Kalyanaraman, D M Rausch, J Osborne, et al.

Science (New York, N.Y.)|August 5, 1988

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicityJ D Lifson, K M Hwang, P L Nara, et al.

Blood|May 1, 1988

High titer anti-HIV antibody reactivity associated with a paraprotein spike in a homosexual male with AIDS related complexV L Ng, K M Hwang, G R Reyes, et al.

Journal of Medicinal Chemistry|July 24, 1992

Antitumor agents. 134. New shiraiachrome-A- and calphostin-C-related perylene derivatives as cytotoxic and antiviral agents and inhibitors of protein kinase CH K Wang, J X Xie, J J Chang, et al.

Annals of the New York Academy of Sciences|January 1, 1990

Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV therapeutic agentsD M Rausch, K M Hwang, M Padgett, et al.

Cancer Research|November 1, 1976

Mode of action of the bioreductive alkylating agent, 2,3-bis(chloromethyl)-1,4-naphthoquinoneL A Cosby, R S Pardini, R E Biagini, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989

GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineageM S McGrath, K M Hwang, S E Caldwell, et al.

Science (New York, N.Y.)|October 28, 1983

Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumorJ N Weinstein, M A Steller, A M Keenan, et al.

Pageof 3